This article, written with co-authors Bruce H. Kobayashi, Joshua D. Wright, and Douglas H. Ginsburg, examines the economics of litigation and settlement of patent disputes arising from Paragraph IV Abbreviated New Drug Application (ANDA) filings under the Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman Act) within the framework set out in Actavis.
Antitrust Economics for Lawyers 2026
Designed for antitrust practitioners without requiring an economics background, the book explains complex concepts in an accessible but rigorous way, pairing...